Neovascularization is an important event in proliferative diabetic retinopathy (PDR), where various secretory proteins including multiple growth factors are considered to be involved in this process. We searched for secretory proteins expressed in a surgical specimen obtained from the eyes of patients with PDR. Methods: We developed the oligo-cap signal sequence trap (SST) strategy which enables us to screen for secretory or membrane proteins from a minimal starting material. Using this method, we were able to screen a cDNA library constructed from a surgical specimen obtained from the eyes of the patients with PDR. 
Introduction
Diabetic retinopathy (DR) is one of the most frequent causes of blindness. Proliferative diabetic retinopathy (PDR) is a serious state in which the progression of DR is accelerated, and various secretory proteins, including multiple growth factors, are considered to be involved in this process. Among these, prompted to search for secretory proteins expressed in the minimal specimen obtained from surgery on a PDR patient. Our approach should provide direct and informative evidence of the genes expressed and possibly involved in the development of PDR.
Materials and Methods

Cloning of Secretory Factors Expressed in PDR
The oligo-cap SST method combines the Oligocap method and SST-REX (signal sequence trap by retrovirus-mediated expression screening system [2] [3] [4] . Starting tissue materials were obtained from vitreoretinal surgery of PDR patients under informed consent. Briefly, RNAs were extracted from the tissue obtained at surgery, and treated with the FirstChoice RLM-RACE procedure (Ambion). The RNA was then ligated to a RNA adaptor containing BstXI site. cDNA was synthesized from RNA ligated with the adaptor using a DNA primer containing the BstXI sites and random hexamers at the 3' end using the ReverScript System (WAKO). The cDNA was then amplified by polymerase chain reaction, digested with BstXI, and inserted into the BstXI site of the pMX-SST vector plasmid. The cDNA library was amplified in DH10B cells (Invitrogen) and transfected into the packaging cell line PlatE to construct a high titer retroviral cDNA library. The library was infected to an interleukin-3 (IL-3)-dependent cell line, Ba/F3 cells. After infection, IL-3-independent Ba/F3 cells were selected in the medium without IL-3. The cDNAs were amplified from the genome extracted from IL-3-independent Ba/F3 cells and sequenced.
Sample Collection
Vitreous fluid samples were obtained from patients who underwent vitreous surgery, after informed concent. Samples of vitreous fluid were collected into sterile tubes at the time of vitreoretinal surgery and immediately stored at 80 until analysis. Written informed consent was obtained from all patients, and the study was approved by the appropriate ethics committee. Vitreous fluids were assayed quantitatively for secreted protein acidic and rich in cystein (SPARC) by an osteonectin ELISA kit according to the manufacturer's instructions (Haematologic Technologies, Inc.).
Animals
Sprague-Dawley rats were purchased from CLEA (Tokyo, Japan). Diabetes was induced by a single injection of STZ (60 mg/kg body wt; Sigma), dissolved in citrate buffer (PH4.5) into a tail vein. Long-Evans rats, 8 to 12 weeks of age, were obtained from CLEA (Tokyo, Japan). Animals were handled in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. All animal husbandry and animal experiments were consistent with the University of Tsukuba's Regulations of Animal Experiments and were approved by the Animal Experiment Committee, University of Tsukuba 5, 6) .
In Situ Hybridization
DIG-labeled RNA probes for SPARC were created as follows. Part of the SPARC cDNA fragment was PCR-amplified using 5´-TTGCCACAAAGTG-CACCCT-3´ and 5´-ATTCGGTCAGCTCAGAG-TCCAG-3´ primers. The PCR fragment was cloned into pGEM-T Easy vector (Promega) and analyzed by sequencing. These plasmids were linearized with Nde I for an anti-sense probe to detect SPARC expression, and Nco I for a sense probe, as a negative control experiment. These linearized plasmids were transcribed in vitro with DIG-11-uridine-5´-triphosphate (Roche) along with 1 unit/ L T7 polymerase and SP6 polymerase (Promega). In situ hybridization was performed according to the manufacturer's protocol on the Nonradioactive in Situ Hybridization Application Manual (Roche).
Delivery of Adenovirus
Long-Evans rats were used for subretinal injections of recombinant adenovirus. The animals were anesthetized by pentobarbital sodium delivered by intraperitoneal injection. The eyes were further treated with tropicamide and phenylephrine hydrochloride drops. A 30-gauge needle was used to make a shelving puncture of the sclera. A 30-gauge needle was injected in a tangential direction under an operating microscope. For histology and fluorescein angiogram studies, each eye was injected with 5 L adenoviral stock containing 1 10 7 particles of recombinant adenoviruses expressing either GFP, SPARC, VEGF, or a combination of SPARC and VEGF, respectively, according to the procedure previously described [7] [8] [9] . Each adenoviral stock was delivered to the subretinal space. Immediately after subretinal injection, a circular bleb was usually observed under the operating microscope. The success of each subretinal injection was further confirmed by the observation of partial retina detachment, as seen by indirect ophthalmoscopy. Retinal detachment due to subretinal injections ranged over 1/4 to 1/2 of the retina.
Fluorescein Angiography
Rats were anesthetized and perfused intravenously with 0.4 mL PBS containing 50 mg/mL FITC-labeled dextran (Sigma) as described 10) .
Results
Oligo-Cap SST Screening of the PDR cDNA Library
From the initial screen, we obtained 291 cDNAs of putative secretory or membrane proteins. Of these, 144 clones were found to be SPARC (Table 1A) . Independent screening was repeated to confirm the result, using surgical tissue from another patient, which also demonstrated 137 of 169 cloned cDNAs of secreted proteins to be SPARC (Table 1B) . These results strongly suggested that SPARC is highly expressed and may be a major player in the proliferative retinal tissue of PDR.
SPARC is Increased in Vitreous Fluid from Patients with Proliferative Diabetic Retinopathy
To confirm the observation obtained from the oligo-cap SST screen, we next measured the concentration of SPARC in vitreous fluid obtained from patients who underwent vitreous surgery. The concentration of SPARC in vitreous samples from 64 patients undergoing vitreous surgery (40 with PDR, 13 with diabetic vitreous hemorrhage (DM VH), and 11 with diabetic macular edema (DME)), and 8 nondiabetic patients who received vitrectomy for macular hole (MH) were analyzed. As expected, SPARC was significantly increased in patients with PDR (285.3 ng/ mL average), compared to patients with MH (124.8 ng/mL average) (p 0.005), and DME (127.6 ng/mL) (p 0.005) (Fig. 1) . SPARC concentration was also shown to be increased in the vitreous of DM VH (326.1 ng/mL) compared to MH (p 0.01), and with DME (p 0.001). There were no significant differences between the vitreous of DME and MH.
Localization of SPARC in Streptozotocin-Induced Diabetes in Rat Eyes
In situ hybridization was performed to analyze the expression of SPARC and VEGF in sections of eyes from STZ-induced diabetic rats. Previous studies demonstrated that VEGF expression in the retina of STZ-induced diabetic rats was upregulated predominantly in the ganglion cell layer (GCL), inner nuclear layer (INL) and outer nuclear layer (ONL) 11) . The expression level of SPARC was shown to be markedly increased in the retina of diabetic rats at 6 months after STZ injection. Increased expression of SPARC was observed in INL and ONL of diabetic rats compared to control rats ( Fig. 2A, B) . We also confirmed that the expression of VEGF in the retina of STZ-induced diabetic rat at 6 months was upregulated in INL and ONL, where no significant VEGF expression was observed in the retina of control rats (Fig. 2C, D) . Our results suggested that SPARC expression is increased in retina exposed to high glucose.
Fluorescein Angiography of AdCMV.SPARCInjected Eyes
In order to test whether SPARC may play a significant role in the progression of proliferative diabetic retinopathy, we injected recombinant adenoviruses that express SPARC, VEGF and GFP into the RPE of rats. Fluorescein angiogram was performed to detect possible vascular leakage to see if these adenoviruses have a permeability effect on blood vessels. Twenty-two eyes of pigmented Long-Evans rats were subjected to subretinal injection with AdCMV.SPARC, AdCMV.VEGF, or both AdCMV.SPARC and AdCMV.VEGF. Each eye was injected with 1 10 7 particles. All animals were analyzed 4 weeks after injection. Fluorescein angiograms representative of a control phosphate-buffered saline-injected eye (Fig. 3A) and a control virus (AdCMV.GFP)-injected eye, are shown (Fig. 3B) . Previous studies demonstrated that leakage by fluorescein angiography is observed in AdCMV.VEGF-injected eyes 8, 9, 12) . Partial leakage was also seen in our results of AdCMV.VEGF-injected eyes (Fig. 3E) . A similar leaky area was demonstrated in AdCMV.SPARCinjected eyes (Fig. 3C, D) . In eyes injected with both AdCMV.SPARC and VEGF, relatively massive leakage was observed (Fig. 3F) . These data demonstrated that forced expression of SPARC in the RPE had a permeability effect on blood vessels which is comparable to, and additive to, the effect of VEGF.
Histological Analysis of AdCMV.SPARC-Injected Eyes
To determine whether the leakage detected by fluorescein angiography is from previous new blood vessel formation and not due only to leakage from existing blood vessels, eyes were harvested 4 weeks postinjection and analyzed by histology. Normal rat retina is shown in Fig. 3G . Eyes injected with AdCMV.GFP, as a control, did not show any change, except for a small area around the injection site (Fig. 3H) . Detachment of the neural retina from the RPE cell layer on both sides of the scar occurred during fixation and, provided all cell layers were present, was considered normal.
Development of choroidal neovascularization (CNV) (white arrow) was observed in histological analysis of an AdCMV.VEGF-injected eye (Fig. 3K) , which is consistent with a previous report 9) . In AdCMV.SPARC-injected eyes, preretinal neo-vascularization (dark arrowheads), proliferation of RPE (dark arrows) and the growth of blood vessels from the retinal vasculature into inner plexiform layers (asterisk), were demonstrated (Fig. 3I, J) . In eyes injected with both AdCMV.SPARC and VEGF viruses, both of the changes seen in either AdCMV.SPARC-or 18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41   NM_003118  NM_000088  NM_002294  NM_003299  NM_013697  NM_000491  NM_001908  BC053656  NM_002290  NM_000758  NM_001711  NM_139279  NM_020199  NM_001425  BC014410  NM_020650  NM_002593  NM_024756  NM_006184  NM_000041  NM_020405  NM_002414  NM_177924  NM_007085  NM_023105  NM_001849  BC010507  NM_020010  NM_078474  NM_005211  NM_018259  NM_001961  NM_172355  NM_003123  NM_003278  NM_021983  NM_001219  AF159295  NM_212482  D14043  HSA276485   SPARC/ AdCMV.VEGF-injected eyes were seen (Fig. 3L) . The results of AdCMV.SPARC-injected eyes suggest that the overexpression of SPARC can develop preretinal neovascularization.
Discussion
Neovascularization is an important event in PDR, where various secretory proteins, including multiple growth factors, are considered to be involved in this process. Recently, we developed the Oligo-cap SST strategy which enables us to screen for secretory or membrane proteins from minimal starting material. Using this method, we were able to screen a cDNA library constructed from a surgical specimen obtained from the eyes of patients with PDR. The majority of cloned cDNAs were found to encode SPARC, strongly suggesting that this gene is highly expressed in PDR. Surprisingly, VEGF was not cloned in our experiment, probably because the signal sequence is located at 1032 to 1109 base of the mRNA and was difficult to amplify by PCR; therefore, our result does not exclude the high expression of VEGF in PDR. To confirm our findings, concentrations of SPARC protein in vitreous samples from 64 diabetic patients undergoing vitreous Human SPARC-specific ELISA was performed in vitreous samples from diabetic patients with DME (n 11), DM VH (n 13), PDR (n 40 surgery (40 with PDR, 13 with DM VH, and 11 with DME), and 8 nondiabetic patients who received vitrectomy for MH were analyzed. As expected, SPARC was significantly increased in patients with PDR, compared to patients with MH or DME. SPARC concentration was also shown to be increased in the vitreous of DM VH compared to MH or DME. There were no significant differences between the vitreous of MH and DME. These results indicated that SPARC is highly expressed in the vitreous of patients with proliferative tissue.
To investigate whether high levels of blood glucose may cause an increase in SPARC expression in the retina, we investigated the expression of SPARC in the retina of STZ-induced diabetic rats. As expected, the expression level of SPARC was markedly increased in the retina of STZ-induced diabetic rats compared to normal rats, suggesting that prolonged high levels of blood glucose may cause increased SPARC expression. Furthermore, subretinal injection of recombinant adenovirus expressing SPARC was shown to induce preretinal neovascularization, proliferation of RPE and the growth of blood vessels from the retinal vasculature into inner plexiform layers in the rat eye. These results suggest that in the retina of diabetic rats, a high blood glucose level increases the expression of SPARC, which in turn may directly induce neovascularization. In addition, simultaneous injection of recombinant adenoviruses expressing SPARC and VEGF was shown to have an additive effect on the induction of permeability and proliferation of blood vessels, suggesting that both SPARC and VEGF may be involved in the progression of DR. These findings strongly suggested that SPARC may be a major player involved in the development of diabetic retinopathy.
SPARC is a secreted glycoprotein with a molecular mass of 32 kDa that is associated with development, remodeling, angiogenesis modulates cell adhesion, migration, and proliferation 13) . It has been reported that the generation of proteolytic fragments from SPARC was localized to the tips of growing vessels and the fragment of (K) GHK motif was shown to be released from SPARC by plasmin 14) , MMP-3 15) , and peptides containing this sequence induced angio- genesis in vivo and in vitro 13, 15, 16) . Several studies have suggested a correlation between SPARC and common diseases. It has been reported that chronic diabetic nephropathy was less severe in SPARC-null mice compared to WT mice, when induced to diabetes by STZ 17) . Plasma concentration of SPARC was shown to be increased in patients with coronary artery disease 18) . The migration of retinal pigment cells in proliferative vitreoretinopathy is modulated by SPARC 19) . Interestingly, the levels of SPARC expression in human , which may suggest that SPARC is also involved in regulation by VEGF.
Our results have shown that SPARC may be directly involved in the progression of PDR. The potential of SPARC as a therapeutic target of PDR, as well as other diabetic complications, is an interesting challenge that should be investigated.
